l.erdogan
Submits third-party assay reports on material purchased directly. Based in Beirut.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.08%
n=6
Suppliers covered
3
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043302 | IGF-1 LR3 | CPC | CPC-2512-S2394 | Janoshik | 2026-Q2 | 98.07 | 2.91 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020980 | TB-500 | CPC | CPC-2502-V2965 | PeptideMeter | 2025-Q2 | 98.96 | 4.68 | 93.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019078 | Tirzepatide | JEEP | JEEP-2412-U3223 | Janoshik | 2025-Q2 | 99.21 | 3.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019484 | GHRP-6 | Homopeptide | HOMO-2504-G9629 | Janoshik | 2025-Q2 | 99.93 | 3.08 | 103.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019083 | Tirzepatide | JEEP | JEEP-2412-U3223 | PeptideMeter | 2025-Q2 | 99.50 | 2.48 | 98.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005365 | Semaglutide | CPC | CPC-2309-A2449 | Medutest | 2024-Q1 | 96.82 | 4.81 | 103.0 | Supplier-supplied | 1 | FAIL |
| Supplier | Records | Median purity |
|---|---|---|
| CPC | 3 | 98.07 |
| JEEP | 2 | n<3 |
| Homopeptide | 1 | n<3 |